4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-23-001495
Director bought 110,000 shares at $1.42 ($155,815)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schwartz Aharon Director | 2023-01-03 | Purchase | +110,000 | $1.42 | $155,815 | 174,000 | D |
| Open-market purchases · 110,000 sh · avg $1.42 · $155,815 | |||||||
Loading xslF345X03/tm232297-1_4seq1.xml…